AIHC Capital Management
CENTRAL, K3files as AIHC Capital Management Ltd
$104m in 4 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 14.6% of the portfolio this quarter.
Value
$104m
Stocks
4
Top 10 share
100.0%
Turnover
14.6%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
- Oric PharmaceuticalsORIC39.8% of the fund+56%
- Novabridge BiosciencesNBP5.4% of the fund+27%
Cut
Sold some of their stake.
- Revolution MedicinesRVMD54.5% of the fund-63%
Sold out
Sold their entire stake.
Holdings
- Novabridge BiosciencesNBP
- Share
- 5.4%
- Value
- $6m
- Shares
- 2,878,033
+27%
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Revolution MedicinesRVMD | 54.5% | $57m | 303,133 | -63% |
| Oric PharmaceuticalsORIC | 39.8% | $41m | 3,828,460 | +56% |
| Novabridge BiosciencesNBP | 5.4% | $6m | 2,878,033 | +27% |
| Korro BioKRRO | 0.4% | $398,893 | 30,265 | Held |
Over time and by industry
Value over time
Dec '25
Jun '26
Value is down 2.3% since 31 December 2025.
Where the money is
Health care94.6%
Other5.4%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.